InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Burgstahler David F. Director active across 1 company, notably RVL Pharmaceuticals plc. In total, 2 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €12.2m. History available since 8 August 2022. The latest transaction was disclosed on 27 January 2023 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations